In the past 3 years, the workplace has undergone a pivotal shift. For many businesses the on-site model has become outdated, with more organisations adopting flexible and remote working policies.
A leading pharmaceutical company committed to creating breakthrough drugs needed to adapt to the modern workforce and unite its teams of employees, contractors and third-party business partners across a remote and hybrid working model.
Handling highly sensitive data, they needed to meet stringent governance regulations to enable effective hybrid working. We focussed on implementing the correct governance standards in place to ensure a smooth transition to the new model.
